The effect of escitalopram on sleep problems in depressed patients

Human Psychopharmacology

Volumn 20, Issue 5, 2005, Pages 349-354

  Lader, M ^a   Andersen, H F ^b   Baekdal T ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b H LUNDBECK A S   (Denmark)

Author keywords

Citalopram; Escitalopram; MADRS; Sleep problems

Indexed keywords

BENZODIAZEPINE; CITALOPRAM; ESCITALOPRAM; PLACEBO; ZOLPIDEM;

ADULT; ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; DATA ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; INSOMNIA; MAJOR DEPRESSION; MALE; META ANALYSIS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SCORING SYSTEM; SLEEP; SLEEP DISORDER; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; SLEEP DISORDERS;

EID: 23244448573     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.694     Document Type: Article

References (24)

1. Agargun MY, Kara H, Solmaz M. 1997. Sleep disturbance and suicidal behaviour in patients with major depression. J Clin Psychiatry 58: 249-251.
2. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. 1992. Sleep and psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 49: 651-668.
3. Bielski RJ, Ventura D, Chang C-C. 2004. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. J Clin Psychol 65: 1190-1196.
4. Burke WJ, Gergel I, Bose A. 2002. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 63: 331-336.
5. Doghramji K. 1989. Sleep disorders: a selective update. Hosp Community Psychiatry 40: 29-40.
6. Gorman JM, Korotzer A, Su G. 2002. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectr 7(Suppl. 4): 40-44.
7. Gursky JT, Krahn LE. 2000.The effects of antidepressants on sleep: a review. Harvard Rev Psychiatry 8: 298-306.
8. Hall RC, Platt DE, Hall RC. 1999. Suicide risk assessment: a review of risk factors for suicide in 100 patients who made severe suicide attempts. Psychosomatics 40: 18-27.
9. Jindal RD, Buysse DJ, Thase ME. 2004. Maintenance treatment of insomnia: what can we learn from the depression literature? Am J Psychiatry 161: 19-24.
10. Lepola UM, Loft H, Reines EH. 2003. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 18: 211-217.
11. Lepola U, Wade A, Andersen HF. 2004. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder. Int Clin Psychopharmacol 19: 149-155.
12. Londborg PD, Smith WT, Glaudin V, Painter JR. 2000. Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. J Affect Disord 61: 73-79.
13. Lustberg L, Reynolds CF. 2000. Depression and insomnia: questions of cause and effect. Sleep Med Rev 4: 253-262.
14. Montgomery SA, Åsberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389.
15. Montgomery SA, Huusom AKT, Bothmer J. 2004. A randomised study comparing escitalopram with venlafaxine, XR in primary care patients with major depressive disorder. Neuropsychobiology 50: 57-64.
16. Nierenberg AA, Keefe BR, Leslie VC, et al. 1999. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 60: 221-225.
17. Rapaport MH, Bose A, Zheng H. 2004. Escitalopram continuation treatment prevents relapse of depressive episodes. J Clin Psychiatry 65: 44-49.
18. Reynolds CF, Kupfer DJ. 1987. Sleep research in affective illness: state of the art circa 1987. Sleep 10: 199-215.
19. Rudolph RL, Fabre LF, Feighner JP. 1998. A randomized placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. J Clin Psychiatry 59: 116-122.
20. Thase ME, Simons AD, McGeary J, et al. 1992. Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychol 149: 1046-1052.
21. Tylee A, Gastpar M, Lepine JP, et al. 1999. DEPRESS II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. Int Clin Psychopharmacol 14: 139-151.
22. van Bemmel AL, van den Hoofdakker RH, Beersma DGM, Bouhuys AL. 1993. Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacology 113: 225-230.
23. Wade A, Michael Lemming O, Bang Hedegaard K. 2002. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 17: 95-102.
24. Winokur A, Reynolds CF III. 1994. The effects of antidepressants on sleep physiology. Primary Psychiatry 1: 22-27.